FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
Oppenheimer maintained an Outperform rating on uniQure BV (NASDAQ: QURE), and cut the price target to $23.00 (from $50.00),following the company's 4Q. QURE ended the year with 203.5M (~$230M USD) in cash which estimates show will fund operations through 2018. Next hemophilia data is set to come out in 2Q16, while... More

